Yamamura A, Nosaka K, Tatetsu H, Yasunaga JI.

Successful treatment with EPOCH followed by mogamulizumab for angioimmunoblastic T-cell lymphoma with myelofibrosis and pure red cell aplasia.

Ozaki T, Imada C, Shirakami K, Abe T, Shingai Y, Umeki T, Fukuda A, Ishii K, Shibata H.

Serum Soluble Interleukin-2 Receptor as a Potential Marker for Assessing Disease Activity in the TAFRO Subtype of Idiopathic Multicentric Castleman Disease.

Intern Med 2025.doi: 10.2169/internalmedicine.4791-24.

https://pubmed.ncbi.nlm.nih.gov/39924238/

Tanaka A, Ishitsuka Y, Ohta H, Takenouchi N, Nakagawa M, Koh KR, Onishi C, Tanaka H, Fujimoto A, Yasunaga JI, Matsuoka M.

Integrative analysis of ATAC-seq and RNA-seq for cells infected by human T-cell leukemia virus type 1.

https://pubmed.ncbi.nlm.nih.gov/39746113/

Seki Y, Okamoto K, Ikezoe T, Yamakawa K, Madoiwa S, Uchiyama T, Asakura H, Yamada S, Koga S, Ishikura H, Ito T, Iba T, Uchiba M, Kawasaki K, Kawano N, Gando S, Kushimoto S, Sakamoto Y, Tamura T, Nishio K, Hayakawa M, Matsumoto T, Mayumi T, Wada H; Committee of the Clinical Practice Guidelines for Disseminated Intravascular Coagulation 2024, the Japanese Society on Thrombosis and Hemostasis.

Clinical practice guidelines for management of disseminated intravascular coagulation in Japan 2024. Part 3: solid cancers and vascular abnormalities.

Int J Hematol May;121(5):622-632,2025.doi: 10.1007/s12185-024-03912-y.

https://pubmed.ncbi.nlm.nih.gov/39792236/

Hayakawa M, Seki Y, Ikezoe T, Yamakawa K, Okamoto K, Kushimoto S, Sakamoto Y, Itagaki Y, Takahashi Y, Ishikura H, Mayumi T, Tamura T, Nishio K, Kawazoe Y, Shigeno A, Takatani Y, Tampo A, Nakamura Y, Mochizuki K, Yada N, Kawasaki K, Kiyokawa A, Morikawa M, Uchiba M, Matsumoto T, Asakura H, Madoiwa S, Uchiyama T, Yamada S, Koga S, Ito T, Iba T, Kawano N, Gando S, Wada H; Committee of the Clinical Practice Guidelines for Disseminated Intravascular Coagulation 2024, the Japanese Society on Thrombosis, Hemostasis.

Clinical practice guidelines for management of disseminated intravascular coagulation in Japan 2024: part 4-trauma, burn, obstetrics, acute pancreatitis/liver failure, and others.

Int J Hematol May;121(5):633-652,2025.doi: 10.1007/s12185-025-03918-0.

https://pubmed.ncbi.nlm.nih.gov/39890756/

Grover P, Murata M, Kidiga M, Hayashi S, Ode H, Iwatani Y, Morimoto M, Natsume T, Kaneko A, Yasunaga JI, Matsuoka M, Kuramitsu M, Seki Y, Mizukami T, Akari H.

Identification of natural remission of mother-to-child retroviral transmission.

Liu B, Yasunaga JI, Liang Y, Zhou R, Yang S, Yuan X, Liu J, Zuo X, Miura M, Higuchi Y, Matsumoto T, Toyoda K, Matsuoka M, Ma G.

Identification of AK4 and RHOC as potential oncogenes addicted by adult T cell leukemia.

Shichijo T, Yasunaga JI.

Stratagems of HTLV-1 for persistent infection and the resultant oncogenesis: Immune evasion and clonal expansion.

Leuk Res 16:152:107680,2025.doi: 10.1016/j.leukres.2025.107680.

https://pubmed.ncbi.nlm.nih.gov/40120237/

Kidiga M, Murata M, Grover P, Ode H, Iwatani Y, Seki Y, Kuramitsu M, Morimoto M, Natsume T, Kaneko A, Hayashi S, Yasunaga JI, Matsuoka M, Mizukami T, Akari H.

Identification of occult STLV-1 infection in Japanese macaques.

Yamada R, Arima K, Yano H, Fujiwara Y, Yamashita K, Kanemitsu K, Hanada N, Yasunaga JI, Iwatsuki M, Mikami Y, Komohara Y.

Impact of HTLV-1 infection on clinicopathological characteristics and tumour immune microenvironment in colorectal cancer.

Virchows Arch doi: 10.1007/s00428-025-04074-w.

https://pubmed.ncbi.nlm.nih.gov/40111448/